Long-term study (2005-2010) on the vaccination with BoHV-1 glycoprotein E-deleted marker vaccine in selected two dairy herds in Turkey

ALKAN F., Bilge-Dagalp S., Karapinar Z., TİMURKAN M. Ö., Coskun N., Burgu I.

TROPICAL ANIMAL HEALTH AND PRODUCTION, vol.50, no.2, pp.353-363, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.1007/s11250-017-1440-3
  • Journal Name: TROPICAL ANIMAL HEALTH AND PRODUCTION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.353-363
  • Keywords: BoHV-1, Marker vaccine, ELISA, INFECTIOUS-BOVINE-RHINOTRACHEITIS, RESPIRATORY-DISEASE COMPLEX, HERPESVIRUS-1 INFECTION, CATTLE HERDS, TYPE-1 BHV-1, VIRUS, IMMUNITY, IBR, SEROPREVALENCE, REACTIVATION
  • Ankara University Affiliated: Yes

Abstract

A follow-up study from 2005 to 2010 was carried out in two herds where eradication programme for the bovine herpes virus-1 (BoHV-1) infection depends on the vaccination with inactivated glycoprotein E-deleted vaccine that was started in 2001 following the vaccination with inactivated conventional vaccine between 1999 and 2001. For serological screening, a total of 12,976 sera sampled over several sampling times approximately 6 months of interval during 5 years (2005-2010) were tested for glycoprotein E (gE)- and glycoprotein B-specific antibodies using ELISA. According to the serological evidence, the long-term persistence of BoHV-1 antibodies, success of marker vaccine, first vaccination time of the calves in herds regularly vaccinated, etc. were discussed in this paper. In conclusion, the vaccination programme using gE (-) marker vaccines, with making efforts to prevent the other factors about transmission of infection, was suggested for the eradication of BoHV-1 infection in Turkey as many EU countries. This is the first report on the BoHV-1 eradication programme in some dairy cattle in Turkey.